|
Volumn 197, Issue 2, 2012, Pages 90-
|
The rising cost of vitamin D testing in Australia: Time to establish guidelines for testing
|
Author keywords
[No Author keywords available]
|
Indexed keywords
25 HYDROXYVITAMIN D;
25-HYDROXYVITAMIN D;
BIOLOGICAL MARKER;
DRUG DERIVATIVE;
VITAMIN D;
ANALYTIC METHOD;
AUSTRALIA;
BUDGET;
COST BENEFIT ANALYSIS;
COST CONTROL;
HEALTH CARE COST;
HEALTH CARE FINANCING;
HUMAN;
LETTER;
MEDICARE;
PRACTICE GUIDELINE;
RISK BENEFIT ANALYSIS;
TOTAL QUALITY MANAGEMENT;
VITAMIN D DEFICIENCY;
VITAMIN D TESTING;
ECONOMICS;
AUSTRALIA;
BIOLOGICAL MARKERS;
HEALTH EXPENDITURES;
HUMANS;
PRACTICE GUIDELINES AS TOPIC;
VITAMIN D;
VITAMIN D DEFICIENCY;
|
EID: 84866490369
PISSN: 0025729X
EISSN: 13265377
Source Type: Journal
DOI: 10.5694/mja12.10561 Document Type: Letter |
Times cited : (42)
|
References (2)
|